David Rokach - Nukkleus COO Director
| NUKK Stock | USD 2.41 0.06 2.43% |
Director
David Rokach is COO Director of Nukkleus
| Age | 56 |
| Address | 575 Fifth Ave, New York, NY, United States, 10017 |
| Phone | 212 791 4663 |
| Web | https://www.nukk.com |
Nukkleus Management Efficiency
The company has return on total asset (ROA) of (3.973) % which means that it has lost $3.973 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.4205) %, meaning that it created substantial loss on money invested by shareholders. Nukkleus' management efficiency ratios could be used to measure how well Nukkleus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -9.64 this year. The value of Return On Capital Employed is expected to slide to 2.60. At this time, Nukkleus' Total Current Liabilities is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 957.3 K this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 1.1 M.Similar Executives
| Found 8 records | DIRECTOR Age | ||
| Stephen Chen | Phunware | 42 | |
| Jeremy Krol | Phunware | 48 | |
| Malea Farsai | NetSol Technologies | 55 | |
| Malea JD | NetSol Technologies | 55 | |
| Omar Ghauri | NetSol Technologies | N/A | |
| Angela Diaco | Aware Inc | N/A | |
| Asad Ghauri | NetSol Technologies | 49 | |
| Frank Stansberry | Marketwise | 53 | |
Management Performance
| Return On Equity | -7.42 | ||||
| Return On Asset | -3.97 |
Nukkleus Leadership Team
Elected by the shareholders, the Nukkleus' board of directors comprises two types of representatives: Nukkleus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nukkleus. The board's role is to monitor Nukkleus' management team and ensure that shareholders' interests are well served. Nukkleus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nukkleus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jamal Khurshid, COO Director | ||
| Emil Assentato, President CEO, Treasurer, Secretary, Director | ||
| Yair Ohayon, Investor Officer | ||
| Menachem Shalom, CEO Director | ||
| Morel Levi, Chief Officer | ||
| Andrew MBA, Chief Officer | ||
| Shawn Dilkes, Chief Officer | ||
| David Rokach, COO Director |
Nukkleus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nukkleus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.42 | ||||
| Return On Asset | -3.97 | ||||
| Current Valuation | 55.25 M | ||||
| Shares Outstanding | 25.27 M | ||||
| Shares Owned By Insiders | 24.73 % | ||||
| Shares Owned By Institutions | 5.85 % | ||||
| Number Of Shares Shorted | 2.91 M | ||||
| Price To Earning | (40.00) X | ||||
| Price To Book | 0.69 X | ||||
| Price To Sales | 0.71 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. Anticipated expansion of Nukkleus directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nukkleus assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.93) | Revenue Per Share | Quarterly Revenue Growth (0.95) | Return On Assets | Return On Equity |
Investors evaluate Nukkleus using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nukkleus' intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Nukkleus' market price to deviate significantly from intrinsic value.
It's important to distinguish between Nukkleus' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nukkleus should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nukkleus' market price signifies the transaction level at which participants voluntarily complete trades.